CM – Entera Bio shares an increase in mid-stage osteoporosis study data


Similar title :
Entera Bio (ENTX) -stock ready to surpass 50%: will it hit the $ 7 mark?
Entera Bio Announces Excellent Top-Line Phase 2 BMD Data for EB613, Study Met Primary – and key secondary values ​​…
Entera Bio sees positive results from study on treatment of osteoporosis
Entera Bio shares the rise in mid-stage osteoporosis study data


NASDAQ:ENTX,Osteoporosis,Stock,NASDAQ:ENTX, Osteoporosis, Stock,,,,,

Donnez votre avis et abonnez-vous pour plus d’infos

Vidéo du jour: